Genetic weight loss is reframing obesity medicine by explaining why diets and drugs fail—and how personalized treatment ...

There is a consensus emerging that surgery is most appropriate for people with severe obesity for whom lifestyle ...

The Obesity Association, a division of the American Diabetes Association (ADA), has issued new standards of care on the ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare ...

About half (53%) of Americans say they hear or read about Ozempic, Wegovy and similar drugs extremely or very often.

A new study reveals stopping GLP-1 weight loss drugs leads to rapid weight regain, nearly four times faster than quitting ...

AbbVie Inc. (NYSE:ABBV) is one of the 10 Goldman Sachs undervalued stocks to invest in. On January 14, 2026, Reuters reported ...

A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful treatment for obesity. With just a once-monthly shot of 'MariTide,' ...

Novo Nordisk's FDA-approved Wegovy pill marks a new era in obesity treatment, expanding access to GLP-1 therapy through ...

GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are ...

Children and adolescents should be proactively evaluated and treated for obesity, according to new guidelines from the American Academy of Pediatrics around childhood obesity. The guidelines note that ...

Hardworking Tennesseans like me have tried changes to our diets and exercise to lose weight and maintain healthy lifestyles, but sometimes, those practices are not enough. 2.6 million Tennesseans – ...